Leucovorin Calcium USP For Compounding (API) is a pharmaceutical agent used primarily as a form of folate in various medical treatments. It is commonly employed to reduce the harmful effects of certain chemotherapy drugs, like methotrexate, thereby acting as a "rescue" medication to protect healthy cells and enhance cancer treatment efficacy. Leucovorin Calcium is also used to treat folic acid deficiency and support anemia management. In compounding, it allows healthcare professionals to tailor treatments that optimize therapeutic outcomes while minimizing adverse effects. This API adheres to rigorous quality standards, playing a critical role in oncology, hematology, and overall patient care by supporting cellular health and recovery.
Ships in 2-4 business days.
Leucovorin calcium USP, or leucovorin calcium, is the active pharmaceutical ingredient (API) in the medication Leucovorin, which is used to prevent and treat the toxic effects of folic acid antagonists, such as methotrexate and pyrimethamine, in chemotherapy and other treatments. It is a water-soluble form of folic acid and works by helping the body to produce healthy cells. Leucovorin calcium USP is manufactured according to the United States Pharmacopeia (USP) standards and is used in formulations for various dosage forms, such as tablets, capsules, and injections. It is considered an essential medicine by the World Health Organization (WHO) and is listed on their Model List of Essential Medicines.
Leucovorin calcium USP For Compounding is a medication used in compounding to help reduce the toxic effects of high doses of methotrexate, a chemotherapy drug. It is also used in combination with other medications in the treatment of some types of cancer, and to help protect against bone marrow damage caused by certain chemotherapy drugs. Leucovorin calcium USP For Compounding is also used in the treatment of anemia (low red blood cell count) caused by a deficiency of folic acid.
CAS Number: 1492-15-8
Properties: Light Sensitive | Hygroscopic
Skip to content
